MIRA Pharmaceuticals Files Definitive Proxy Statement

TL;DR

MIRA Pharma proxy filed. Shareholders vote on company matters.

AI Summary

MIRA Pharmaceuticals, Inc. filed its definitive proxy statement on July 26, 2024, for its annual meeting. The filing details the company's governance, executive compensation, and proposals to be voted on by shareholders. Key information includes the company's business address at 1200 Brickell Avenue, Miami, FL, and its former name, Mira1a Therapeutics, Inc., changed on January 12, 2022.

Why It Matters

This filing provides shareholders with crucial information regarding company leadership, executive pay, and voting matters, enabling informed participation in corporate governance.

Risk Assessment

Risk Level: low — This is a routine proxy filing and does not contain new material financial or operational information that would inherently increase risk.

Key Players & Entities

• MIRA Pharmaceuticals, Inc. (company) — Registrant
• Mira1a Therapeutics, Inc. (company) — Former company name
• 20240726 (date) — Filing date
• 1200 Brickell Avenue (location) — Company business address
• Miami, FL (location) — Company business address

FAQ

Key Financial Figures

• $0.0001 — rs of shares of common stock, par value $0.0001 per share (“Common Stock”)

Filing Documents

• formdef14a.htm (DEF 14A) — 688KB
• proxy_001.jpg (GRAPHIC) — 514KB
• proxy_002.jpg (GRAPHIC) — 392KB
• 0001493152-24-029259.txt ( ) — 1936KB

Security Ownership of Certain Beneficial Owners and Management

Security Ownership of Certain Beneficial Owners and Management 23 Certain Relationships and Related Transactions 29 Stockholder Proposals to be Presented at the Next Annual Meeting 31 Availability of Annual Report on Form 10-K 31 Stockholders Sharing the Same Last Name and Address 32 Where You Can Find More Information 32 i MIRA Pharmaceuticals, Inc. 1200 Brickell Avenue Suite 1950 #1183 Miami, FL 33131 (786) 423-9792 ANNUAL MEETING OF STOCKHOLDERS PROXY This proxy statement (the “Proxy Statement”) is being sent to the holders of shares of common stock, par value $0.0001 per share (“Common Stock”) of MIRA Pharmaceuticals, Inc., a Florida corporation (the “Company”), in connection with the solicitation of proxies by our Board of Directors (the “Board”) for use at the Annual Meeting of Stockholders of the Company which will be held at 10:00 a.m. Eastern Standard Time on September 12, 2024, virtually at the following link: https://web.lumiconnect.com/241211965 (the “Annual Meeting”). QUESTIONS AND ANSWERS REGARDING THE ANNUAL MEETING OF STOCKHOLDERS Who is entitled to vote at the Annual Meeting? The Board has fixed the close of business on July 22, 2024 as the record date (the “Record Date”) for a determination of the stockholders entitled to notice of, and to vote at, the Annual Meeting. As of the Record Date, there are 14,780,885 shares of Common Stock of the Company outstanding. Each share of the Common Stock represents one vote that may be voted on each matter that may come before the Annual Meeting. What matters will be voted on at the Annual Meeting? The proposals that are scheduled to be considered and voted on at the Annual Meeting are as follows: 1. To elect five directors to the board of directors of the Company (the “Board”) to serve until the next annual meeting of the stockholders of the Company or until their success

View Full Filing

View this DEF 14A filing on SEC EDGAR